Senores Pharmaceuticals IPO allotment today: Key details investors need to know

The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024. Investors who subscribed to the public offering can check their allotment status on the official websites of BSE, NSE, or Link Intime India, the registrar of the issue.

Subscription details
The Rs 582.11 crore IPO, priced between Rs 372 and Rs 391 per share, saw a remarkable response from investors, with the issue being oversubscribed 93.69 times. The offering received bids for 79.95 crore shares against the 85.34 lakh shares on offer.

Non-Institutional Investors (NIIs) led the charge, oversubscribing their category by 96.30 times, followed by Qualified Institutional Buyers (QIBs) at 94.66 times. Retail Individual Investors (RIIs) subscribed to their reserved portion 90.46 times.

How to check Senores IPO allotment status
Once finalised, investors can verify their allotment status through the following platforms:

1. BSE: Visit BSE Allotment Page.
2. Link Intime India: Use the Link Intime IPO Status.
3. NSE: Access the NSE IPO Allotment Page.

Investors need their PAN, application number, or DP ID/client ID to check the allotment status.

Listing schedule
Shares of Senores Pharmaceuticals are set to debut on the BSE and NSE on Monday, December 30, 2024.

About Senores Pharmaceuticals
Established in 2017, Senores Pharmaceuticals is a research-driven company specialising in developing and manufacturing pharmaceutical products for regulated markets like the US and Canada. With a portfolio of 55 products spanning key therapeutic areas, including antibiotics and antifungal treatments, the company operates in 43 countries and manages three R&D facilities in India and the US.

The IPO proceeds will be used for working capital needs, debt repayment, and general corporate purposes.